Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

154.53
Delayed Data
As of Apr 24
 +1.69 / +1.11%
Today’s Change
95.80
Today|||52-Week Range
160.00
+41.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues872.4M1.2B1.3B1.5B
 
 
 
 
 
Cost of Goods Sold99.1M110.3M92.6M93.6M
 
 
 
 
 
Depreciation And Amortization82.1M133.7M108.1M113.8M
 
 
 
 
 
 
Operating ExpensesGross Income691.2M928.9M1.1B1.3B
 
 
 
 
 
General Expenses328.0M472.1M582.5M653.7M
 
 
 
 
 
Research And Development46.6M85.2M135.3M162.3M
 
 
 
 
 
Total Operating Expenses509.2M716.1M783.2M861.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income363.2M456.8M541.6M626.9M
 
 
 
 
 
Extraordinary Charge-26.6M-261.2M-50.0M-35.9M
 
 
 
 
 
Interest Expense On Debt26.9M52.7M56.9M61.9M
 
 
 
 
 
Equity In Earnings-------379.0K
 
 
Other Expenses-1.7M8.7M1.2M3.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income308.0M151.6M435.9M532.4M
 
 
 
 
 
Income Taxes-91.6M-94.2M-106.4M-135.2M
 
 
 
 
 
Minority Interest0.00-1.1M-1.0K0.00
 
 
 
Net Income216.3M58.4M329.5M396.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.3M59.7M61.2M60.5M
 
 
 
 
 
Shares To Calculate EPS Diluted61.6M62.6M63.0M61.9M
 
 
 
 
 
 
Earnings Per ShareEPS$3.51$0.93$5.23$6.41
 
 
 
 
 
EPS Diluted$3.51$0.93$5.23$6.41